TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.00$ -5.9% vs. previous close Closing price · As of: Nov 16, 2026

No financial statements are available for this stock yet.

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?